SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-17-040460
Filing Date
2017-02-13
Accepted
2017-02-13 16:15:04
Documents
3
Group Members
KEVIN P. STARRMARK LEVINROBERT I. TEPPERTHIRD ROCK VENTURES GP, L.P.TRV GP, LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT NO. 1 d339319dsc13ga.htm SC 13G/A 117370
2 EX-24 d339319dex24.htm EX-24 3666
3 EX-99.1 d339319dex991.htm EX-99.1 7695
  Complete submission text file 0001193125-17-040460.txt   130377
Mailing Address 29 NEWBURY STREET SUITE 401 BOSTON MA 02116
Business Address 29 NEWBURY STREET SUITE 401 BOSTON MA 02116 617-859-3099
THIRD ROCK VENTURES LP (Filed by) CIK: 0001408591 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Subject) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89140 | Film No.: 17599288
SIC: 2834 Pharmaceutical Preparations